enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA approves new COPD drug developed by firm in Raleigh ... - AOL

   www.aol.com/news/fda-approves-copd-drug...

   The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. ... Typically, anti-inflammatory action comes from inhaled corticosteroids, which can increase ...

3. Fluticasone furoate/umeclidinium bromide/vilanterol - Wikipedia

   en.wikipedia.org/wiki/Fluticasone_furoate/...

   Fluticasone furoate/umeclidinium bromide/vilanterol, sold under the brand name Trelegy Ellipta among others, is a fixed-dose combination inhaled medication that is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). [6] [7] The medications work in different ways: fluticasone furoate is an inhaled corticosteroid ...

4. Fluticasone furoate/vilanterol - Wikipedia

   en.wikipedia.org/wiki/Fluticasone_furoate/vilanterol

   Fluticasone furoate/vilanterol, sold under the brand name Breo Ellipta among others, is a combination medication for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. [3] It contains fluticasone furoate, an inhaled corticosteroid, and vilanterol, an ultra-long-acting β 2 agonist (ultra-LABA). [3]

5. Budesonide/glycopyrronium bromide/formoterol - Wikipedia

   en.wikipedia.org/wiki/Budesonide/glycopyrronium...

   Budesonide/glycopyrronium bromide/formoterol, sold under the brand name Breztri Aerosphere among others, is an inhalable fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD). [5] [6] [7] It contains budesonide, glycopyrronium bromide, and formoterol fumarate dihydrate. [5] [6] [7] It is inhaled. [5 ...

6. AstraZeneca's Triple-Combo COPD Inhaler Gets CRL From FDA - AOL

   www.aol.com/news/astrazenecas-triple-combo-copd...

   AstraZeneca (AZN) gets CRL from the FDA for PT010, its triple-combo inhaler to treat COPD.

7. Long-acting beta-adrenoceptor agonist - Wikipedia

   en.wikipedia.org/wiki/Long-acting_beta...

   This second medication in this combination is the synthetic inhaled corticosteroid fluticasone furoate. This product was approved by the FDA in May 2013 as once-daily inhaled therapy for the treatment of chronic obstructive pulmonary disease (COPD) with umeclidinium bromide: Anoro Ellipta.